Editor’s Note
Cheetos and raisins for dinner: The curse of Wilma and why a public sector that can’t figure out a way to get electricity to gas stations seems unlikely to be victorious in the “war on cancer”
Neil Love, MD

Faculty Interviews
Harold J Burstein, MD, PhD
Assistant Professor of Medicine
Breast Oncology Center
Dana-Farber Cancer Institute
Harvard Medical School
Boston, Massachusetts
- Select publications

Charles L Vogel, MD
Medical Director, Cancer Research Network Inc
Plantation, Florida
- Select publications

Eleftherios P Mamounas, MD, MPH
Associate Professor of Surgery
Northeastern Ohio Universities College of Medicine
Medical Director, Aultman Cancer Center
Canton, Ohio
- Select publications

Journal CLUB

• Breast Cancer Journal Club Notes
• Trastuzumab Plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer
• Trastuzumab After Adjuvant Chemotherapy in HER2-Positive Breast Cancer
• E2100: A Randomized Phase III Trial of Paclitaxel versus Paclitaxel Plus Bevacizumab as First-Line Therapy for Locally Recurrent or Metastatic Breast Cancer
• Safety and Efficacy of Two Different Doses of Capecitabine in the
  Treatment of Advanced Breast Cancer (ABC) in Older Women
• Fulvestrant versus Anastrozole for the Treatment of Advanced
  Breast Carcinoma: A Prospectively Planned Combined Survival
  Analysis of Two Multicenter Trials
• Patterns of Care in Medical Oncology: A Case Survey Comparing
  Practices of Breast Cancer Investigators and General Oncologists
  — Section A: Adjuvant Endocrine Therapy

Breast Cancer Update:
A CME Audio Series and Activity

Faculty Disclosures
Editor's Office